<link rel="stylesheet" href="/res/styles.39be4579664c3a48.css">
Artículo

Liver carbohydrates metabolism: A new islet-neogenesis associated protein peptide (INGAP-PP) target

Villagarcía, Hernán Gonzalo Icon; Román, Carolina Lisi Icon; Castro, María Cecilia Icon; González Arbeláez, Luisa Fernanda Icon; Ronco, Maria Teresa Icon; Frances, Daniel Eleazar Antonio Icon; Massa, Maria Laura Icon; Maiztegui, Barbara Icon; Flores, Luis Emilio Icon; Gagliardino, Juan Jose Icon; Francini, Flavio Icon

Otros responsables

Fecha

03/2018

Editorial

Elsevier Science Inc

Revista

Peptides

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

0196-9781

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

Islet-Neogenesis Associated Protein-Pentadecapeptide (INGAP-PP) increases β-cell mass and enhances glucose and amino acids-induced insulin secretion. Our aim was to demonstrate its effect on liver metabolism. For that purpose, adult male Wistar rats were injected twice-daily (10 days) with saline solution or INGAP-PP (250 μg). Thereafter, serum glucose, triglyceride and insulin levels were measured and homeostasis model assessment (HOMA-IR) and hepatic insulin sensitivity (HIS) were determined. Liver glucokinase and glucose-6-phosphatase (G-6-Pase) expression and activity, phosphoenolpyruvate carboxykinase (PEPCK) expression, phosphofructokinase-2 (PFK-2) protein content, P-Akt/Akt and glycogen synthase kinase-3β (P-GSK3/GSK3) protein ratios and glycogen deposit were also determined. Additionally, glucokinase activity and G-6-Pase and PEPCK gene expression were also determined in isolated hepatocytes from normal rats incubated with INGAP-PP (5 μg/ml). INGAP-PP administration did not modify any of the serum parameters tested but significantly increased activity of liver glucokinase and the protein level of its cytosolic activator, PFK-2. Conversely, INGAP-PP treated rats decreased gene expression and enzyme activity of gluconeogenic enzymes, G-6-Pase and PEPCK. They also showed a higher glycogen deposit and P-GSK3/GSK3 and P-Akt/Akt ratio. In isolated hepatocytes, INGAP-PP increased GK activity and decreased G-6-Pase and PEPCK expression. These results demonstrate a direct effect of INGAP-PP on the liver acting through P-Akt signaling pathway. INGAP-PP enhances liver glucose metabolism and deposit and reduces its production/output, thereby contributing to maintain normal glucose homeostasis. These results reinforce the concept that INGAP-PP might become a useful tool to treat people with impaired islet/liver glucose metabolism as it occurs in T2D.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-nd